| Is Bristol Myers Squibb Stock a Buy? | 11/21 08:00 | fool.com |
| Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks | 11/21 04:33 | fool.com |
| Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It | 11/20 10:06 | zacks.com |
| Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript) | 11/19 16:05 | seekingalpha.com |
| Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms | 11/19 06:59 | businesswire.com |
| Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases | 11/18 13:24 | benzinga.com |
| Bristol-Myers Squibb: Buy This Bargain Before It's Gone | 11/17 11:47 | seekingalpha.com |
| 6 of Wall Street's Most Beloved High-Yield Stocks Are On Sale | 11/17 08:44 | 247wallst.com |
| Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer | 11/15 08:23 | businesswire.com |
| Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors | 11/15 06:59 | businesswire.com |